Stockreport

Purple Biotech Reaches Recommended Phase 2 Dose for NT219

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF REHOVOT, Israel, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing fir [Read more]